Posted by Michael Wonder on 27 May 2021
'Anticancer drug should extend life for 22 months to get insurance benefits'
27 May 2021 - A research team at National Cancer Center has found that the public believes that for an anticancer drug to receive reimbursement, it should extend the survival period by at least 22 months.
While the recent increase in anticancer drugs has become a beacon of hope to some patients, including these new anticancer drugs in the National Health Insurance Service's reimbursement list greatly affects the financial soundness of the National Health Insurance and acts as a burden on the national economy as a whole.
